AUG 20, 2026 · PHASE 3 TRIAL
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
ClinicalTrials.gov
This is a registered Phase 3 trial not yet recruiting with no results posted; it describes a planned study design and primary endpoint only.
Reported
Planned sample size500
PhasePhase 3
Primary outcome measurePercent change in body weight from baseline…